Faber WR - Search Results

1

Biologics in Leprosy: A Systematic Review and Case Report.

Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, Walker SL. Cogen AL, et al. Among authors: faber wr. Am J Trop Med Hyg. 2020 May;102(5):1131-1136. doi: 10.4269/ajtmh.19-0616. Am J Trop Med Hyg. 2020. PMID: 32157993 Free PMC article.

2

Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Iyer A, Hatta M, Usman R, Luiten S, Oskam L, Faber W, Geluk A, Das P. Iyer A, et al. Clin Exp Immunol. 2007 Nov;150(2):210-6. doi: 10.1111/j.1365-2249.2007.03485.x. Clin Exp Immunol. 2007. PMID: 17937676 Free PMC article.

3

Preventing nerve function impairment in leprosy: validation and updating of a prediction rule.

Schuring RP, Richardus JH, Steyerberg EW, Pahan D, Faber WR, Oskam L. Schuring RP, et al. Among authors: faber wr. PLoS Negl Trop Dis. 2008;2(8):e283. doi: 10.1371/journal.pntd.0000283. Epub 2008 Aug 27. PLoS Negl Trop Dis. 2008. PMID: 18846229 Free PMC article.

4

Reservoirs and transmission routes of leprosy; A systematic review.

Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T. Ploemacher T, et al. Among authors: faber wr. PLoS Negl Trop Dis. 2020 Apr 27;14(4):e0008276. doi: 10.1371/journal.pntd.0008276. eCollection 2020 Apr. PLoS Negl Trop Dis. 2020. PMID: 32339201 Free PMC article.

5

Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.

Iyer A, van Eijk M, Silva E, Hatta M, Faber W, Aerts JM, Das PK. Iyer A, et al. Clin Immunol. 2009 Jun;131(3):501-9. doi: 10.1016/j.clim.2009.02.003. Clin Immunol. 2009. PMID: 19307157

6

Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions.

Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, Schumann RR, Oskam L. Schuring RP, et al. Among authors: faber wr. J Infect Dis. 2009 Jun 15;199(12):1816-9. doi: 10.1086/599121. J Infect Dis. 2009. PMID: 19456232

7

[Leprosy in The Netherlands in the period 1970-1991].

Post E, chin-A-Lien RA, Bouman C, Naafs B, Faber WR. Post E, et al. Among authors: faber wr. Ned Tijdschr Geneeskd. 1994 Sep 24;138(39):1960-3. Ned Tijdschr Geneeskd. 1994. PMID: 7935946 Dutch.

8

First reported case of Mycobacterium ulcerans infection in a patient from China.

Faber WR, Arias-Bouda LM, Zeegelaar JE, Kolk AH, Fonteyne PA, Toonstra J, Portaels F. Faber WR, et al. Trans R Soc Trop Med Hyg. 2000 May-Jun;94(3):277-9. doi: 10.1016/s0035-9203(00)90320-1. Trans R Soc Trop Med Hyg. 2000. PMID: 10974998

9

Serial measurement of serum cytokines, cytokine receptors and neopterin in leprosy patients with reversal reactions.

Faber WR, Iyer AM, Fajardo TT, Dekker T, Villahermosa LG, Abalos RM, Das PK. Faber WR, et al. Lepr Rev. 2004 Sep;75(3):274-81. Lepr Rev. 2004. PMID: 15508904

10

Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.

Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM. Feuth M, et al. Among authors: faber wr. Lepr Rev. 2008 Sep;79(3):254-69. Lepr Rev. 2008. PMID: 19009975 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page